Harbor Investment Advisory, LLC Abb Vie Inc. Transaction History

Harbor Investment Advisory, LLC

$1.4 Billion
Q3 2025

A detailed history of Harbor Investment Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 21,868 shares of ABBV stock, worth $5.12 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

21,868

Previous 21,889 0.1%

Holding current value

$5.12 Million

Previous $4.06 Million 24.61%

% of portfolio

0.36%

Previous 0.31%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$184.85 - $231.54 $3,881 - $4,862	-21 Reduced 0.1%	21,868 $5.06 Million
Q2 2025 Jul 01, 2025	BUY	$170.16 - $206.27 $84,569 - $102,516	497 Added 2.32%	21,889 $4.06 Million
Q1 2025 Apr 09, 2025	SELL	$169.2 - $216.66 $67,680 - $86,664	-400 Reduced 1.84%	21,392 $4.48 Million
Q4 2024 Jan 16, 2025	SELL	$164.99 - $203.87 $88,929 - $109,885	-539 Reduced 2.41%	21,792 $3.87 Million
Q3 2024 Oct 04, 2024	SELL	$163.84 - $199.33 $89,620 - $109,033	-547 Reduced 2.39%	22,331 $4.41 Million

Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $324,285 - $378,692	2,095 Added 10.08%	22,878 $3.92 Million
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $22,534 - $25,676	141 Added 0.68%	20,783 $3.78 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $64,534 - $72,680	-469 Reduced 2.22%	20,642 $3.2 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $228,839 - $264,915	-1,713 Reduced 7.51%	21,111 $3.15 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $85,866 - $106,855	-648 Reduced 2.76%	22,824 $3.08 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $433 - $499	3 Added 0.01%	23,472 $3.74 Million
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $169,429 - $203,190	1,225 Added 5.51%	23,469 $0
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $48,852 - $56,030	-364 Reduced 1.61%	22,244 $2.99 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $161,703 - $205,578	-1,175 Reduced 4.94%	22,608 $3.46 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $22,568 - $28,001	-171 Reduced 0.71%	23,783 $3.86 Million
Q4 2021 Jan 10, 2022	SELL	$107.43 - $135.93 $26,427 - $33,438	-246 Reduced 1.02%	23,954 $3.24 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $180,135 - $204,480	-1,693 Reduced 6.54%	24,200 $2.61 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $79,959 - $89,079	760 Added 3.02%	25,893 $2.92 Million
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $22,812 - $25,114	-223 Reduced 0.88%	25,133 $2.72 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $7,727 - $10,432	96 Added 0.38%	25,356 $2.72 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $15,206 - $17,846	177 Added 0.71%	25,260 $2.21 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $32,649 - $43,690	445 Added 1.81%	25,083 $2.46 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $35,604 - $53,980	-552 Reduced 2.19%	24,638 $1.88 Million
Q4 2019 Jan 16, 2020	BUY	$72.13 - $90.25 $1.82 Million - $2.27 Million	25,190 New	25,190 $2.23 Million

Others Institutions Holding ABBV

# of Institutions

4,490

Shares Held

1.28B

Call Options Held

17.1M

Put Options Held

15.4M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Account

Harbor Investment Advisory, LLC Abb Vie Inc. Transaction History